COMT Gene Variant: What It Means for Hormones, Mood, and Stress

The COMT gene variant is one of the most clinically significant genetic findings for women with hormonal, mood, and stress-related symptoms. It affects how efficiently your body clears oestrogen, neurotransmitters, and stress hormones, and it frequently intersects with MTHFR, PMDD, and oestrogen dominance.

What Is COMT?

COMT stands for catechol-O-methyltransferase. It is an enzyme responsible for breaking down catecholamines (dopamine, adrenaline, noradrenaline) and catechol oestrogens (intermediate oestrogen metabolites) via methylation. The COMT Val158Met polymorphism is the most studied variant and reduces enzyme activity by approximately 40 percent in heterozygous carriers and 75 percent in homozygous carriers [1].

How COMT Affects Health

Oestrogen Clearance and Hormonal Health

COMT is a critical step in oestrogen metabolism. When COMT activity is reduced, catechol oestrogens accumulate in tissues rather than being efficiently cleared. These intermediate metabolites, particularly 4-hydroxyoestrogen, are genotoxic and pro-inflammatory [2]. This is associated with increased risk of oestrogen-sensitive conditions and more severe hormonal symptoms.

Women with slow COMT variants often experience more severe PMDD, worse perimenopause symptoms, and more pronounced oestrogen dominance effects. Histamine intolerance also frequently co-occurs given the methylation overlap.

Neurotransmitter Clearance

COMT is the primary breakdown enzyme for dopamine and adrenaline in the prefrontal cortex. Slow COMT variants result in higher dopamine and adrenaline levels in the brain, which can confer benefits (sharper focus, higher motivation under low stress) but also increases vulnerability to anxiety, rumination, and stress reactivity under pressure [3].

This "warrior-worrier" framing is useful: slow COMT women tend to be high-performing and cognitively sharp in calm conditions, but hit harder by acute stress, overwhelm, and hormonal fluctuations. The cortisol and HPA axis connection is significant here.

Pain Sensitivity

COMT variants are associated with altered pain sensitivity. Slow COMT variants correlate with higher pain sensitivity, including menstrual pain, fibromyalgia, and chronic pain conditions [4].

Nutritional Support for Slow COMT

Methylation Support

COMT uses S-adenosylmethionine (SAMe) as a methyl donor. Supporting the methylation cycle through adequate methylfolate, methylcobalamin (B12), and P5P (B6) keeps SAMe available and COMT function optimal. See the full article on MTHFR and methylation for the detailed protocol, particularly if you carry both MTHFR and COMT variants.

Magnesium

Magnesium is a required cofactor for COMT activity. Deficiency directly impairs COMT function. Given that magnesium is also a GABA modulator and cortisol regulator, it is doubly important for slow COMT individuals dealing with stress and hormonal symptoms.

Support Oestrogen Clearance

Reducing the oestrogen load that COMT must process is a key strategy. This includes:

• Cruciferous vegetables (broccoli, cauliflower, Brussels sprouts) which support Phase I oestrogen metabolism via glucosinolates

• DIM (diindolylmethane) to direct oestrogen metabolism toward less reactive metabolites

• Calcium-D-glucarate to support Phase II glucuronidation of oestrogen

• Fibre and a healthy gut microbiome to prevent oestrogen recirculation via the oestrobolome

Reduce Catecholamine Load

For slow COMT individuals, reducing the catecholamine burden COMT needs to clear is therapeutic. This means:

• Managing the stress response through nervous system regulation

• Limiting caffeine, which directly increases catecholamine production

• Adequate sleep (chronic sleep deprivation drives adrenaline output)

• Strategic exercise: regular moderate movement supports catecholamine clearance, while excessive high-intensity training can increase adrenaline load

Avoid High-Catechol Foods in Excess

Catechol-rich foods including green tea (EGCG), quercetin, and coffee inhibit COMT activity directly. While these are healthy in moderation for most people, slow COMT individuals may benefit from reducing concentrated supplemental forms.

Testing and Assessment

COMT status can be identified through nutrigenomic panels. Functional assessment should include hormone testing (particularly oestrogen metabolite ratios via DUTCH test or urine oestrogen metabolites), homocysteine, and neurotransmitter markers where relevant. Functional testing provides the full clinical picture needed to personalise support.

Dealing with hormonal mood swings, anxiety, or PMDD and wondering about COMT?

Book a Clinical Case Assessment with Kirstie to explore whether genetic variants are contributing to your symptoms and what a personalised nutrition approach looks like.

Book Your Free Discovery Call

References

• Lachman HM, et al. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics. 1996;6(3):243-250. PubMed

• Cavalieri EL, Rogan EG. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers. Annals of the New York Academy of Sciences. 2006;1089:286-301. PubMed

• Egan MF, et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences. 2001;98(12):6917-6922. PubMed

• Zubieta JK, et al. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science. 2003;299(5610):1240-1243. PubMed